A Study of Lasmiditan in Healthy Participants

Inclusion Criteria: * Are overtly healthy males or females, as determined by medical history and physical examination. * Have a body mass index (BMI) of 19 to 35 kilograms per meter squared (kg/m²) inclusive, at the time of screening. Exclusion Criteria: * Have known allergies to lasmiditan, related compounds or any components of the formulation. * Have an abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study. * Show evidence of active renal disease or estimated glomerular filtration rate (eGFR) less than 60 milliliter per minute (mL/min) per 1.73 m². * Show evidence of or positive serology for human immunodeficiency virus (HIV) infection, hepatitis B or C. * Are women with a positive pregnancy test or women who are lactating. * Have a clinically significant abnormality in the neurological examination. * Have a history of syncope, presyncopy, uncontrolled vertigo, postural dizziness, or at risk for falls, as judged to be clinically significant by the investigator. * Have orthostatic hypotension with or without dizziness and/or syncope at screening or Day -1 upon repeat testing, or a history of it.